HOTH (Hoth Therapeutics, Inc. Common Stock) Stock Analysis - AI Report

Hoth Therapeutics, Inc. Common Stock (HOTH) is a publicly traded Healthcare sector company. As of May 21, 2026, HOTH trades at $0.60 with a market cap of $11.72M and a P/E ratio of -0.66. HOTH moved +0.10% today. Year to date, HOTH is -43.41%; over the trailing twelve months it is -29.07%. Its 52-week range spans $0.49 to $3.80. Rallies surfaces HOTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on HOTH?

Rallies AI research for HOTH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

HOTH Key Metrics

Key financial metrics for HOTH
MetricValue
Price$0.60
Market Cap$11.72M
P/E Ratio-0.66
EPS$-0.90
Dividend Yield0.00%
52-Week High$3.80
52-Week Low$0.49
Volume899
Avg Volume0
Revenue (TTM)$0
Net Income$-12.47M
Gross Margin0.00%

Latest HOTH News

Recent HOTH Insider Trades

  • Knie Robb bought 25.00K (~$16.75K) on Aug 16, 2024.
  • Knie Robb bought 10.00K (~$3.90K) on Sep 19, 2022.
  • Knie Robb bought 10.00K (~$4.00K) on Sep 16, 2022.

HOTH Analyst Consensus

HOTH analyst coverage data. Average price target: $0.00.

Common questions about HOTH

What is the AI research view on HOTH?
Rallies AI research for HOTH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for HOTH?
Rallies AI research for HOTH combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is HOTH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HOTH. It does not provide personalized investment advice.
HOTH

HOTH